STAY UP-TO-DATE
Latest News
Contact Us.
For more information, please feel free to get in touch by completing the enquiry form. We aim to respond to all enquiries within 24 hours.

Grant forms part of £1.2M project to customise Tagomics’ multiomic profiling platform for early detection of colorectal cancer.
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.
Tagomics has developed Interlace™, a seamless solution for multiomic profiling that enables the identification of disease-associated DNA biomarkers from a range of sample types.
Tagomics, a UK-based startup, has recently emerged from stealth with a new way to look at methylation, or lack thereof, in the human genome.
Current approaches for the study of DNA methylation and other modified bases focus on the modified fraction of the genome.
Tagomics, developers of a cutting-edge platform for comprehensive disease insight and diagnosis, today announces a £6.7m funding round.
Grant forms part of £1.2M project to customise Tagomics’ multiomic profiling platform for early detection of colorectal cancer.
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.
Tagomics has developed Interlace™, a seamless solution for multiomic profiling that enables the identification of disease-associated DNA biomarkers from a range of sample types.
Tagomics, a UK-based startup, has recently emerged from stealth with a new way to look at methylation, or lack thereof, in the human genome.
Current approaches for the study of DNA methylation and other modified bases focus on the modified fraction of the genome.
Tagomics, developers of a cutting-edge platform for comprehensive disease insight and diagnosis, today announces a £6.7m funding round.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance your experience.
Yes, I Accept
Cookie settings